Dr. Gary L Scholl, D.C. Chiropractor - Sports Physician Medicare: Not Enrolled in Medicare Practice Location: 7700 Gunston Plz # A, Lorton, VA 22079 Phone: 703-339-5458 Fax: 703-339-0406 |
Suzanne Dudko, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 9010 Lorton Station Blvd, Suite 110, Lorton, VA 22079 Phone: 703-436-2207 Fax: 703-879-3484 |
Moussa Sylla, DC Chiropractor - Independent Medical Examiner Medicare: Not Enrolled in Medicare Practice Location: 7607 Wildwood Ct Apt B2, Lorton, VA 22079 Phone: 443-739-6150 |
News Archive
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
"[P]articipants at a symposium held last week by the U.K. Consortium on AIDS and International Development warned that progress on HIV and tuberculosis (TB) vaccines could be jeopardized by the recent downturn in global health funding," BMJ reports.
The peer groups teenage girls identify with determine how they decide to control their own figure. So reports a new study by Dr. Eleanor Mackey from the Children's National Medical Center in Washington DC, and her colleague Dr. Annette La Greca from the University of Miami.
Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.
› Verified 7 days ago